JPH09505733A - エンドテリン変換酵素 - Google Patents
エンドテリン変換酵素Info
- Publication number
- JPH09505733A JPH09505733A JP7514199A JP51419995A JPH09505733A JP H09505733 A JPH09505733 A JP H09505733A JP 7514199 A JP7514199 A JP 7514199A JP 51419995 A JP51419995 A JP 51419995A JP H09505733 A JPH09505733 A JP H09505733A
- Authority
- JP
- Japan
- Prior art keywords
- endothelin
- converting enzyme
- seq
- ece
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6497—Endothelin-converting enzyme (3.4.24.71)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24071—Endothelin-converting enzyme 1 (3.4.24.71)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.エンドテリン変換酵素において、該エンドテリン変換酵素がSEQ ID NO:36に記載のポリペプチド配列または該配列の、なおエンドテリン変換酵 素の酵素活性、抗原の性質または配位子に対する親和力を有する部分配列を含有 することを特徴とする、エンドテリン変換酵素。 2.請求項1記載のエンドテリン変換酵素をコード化し、かつ a)SEQ ID NO:35に記載の構造を有するDNA配列、 b)SEQ ID NO:36に記載の構造を有するタンバク質をコード化す るDNA配列によって形成される群から選択されているDNA配列。 3.請求項2記載のDNA配列を使用しながらエンドテリン変換酵素を遺伝子技 術的に製造するための方法。 4.請求項1記載のエンドテリン変換酵素を製造する方法において、哺乳動物細 胞をエンドテリン変換酵素の過剰生産のためにエンドテリン変換酵素の阻害剤で 刺激し、この細胞からエンドテリン変換酵素を常用のタンパク質化学的方法で単 離することを特徴とする、請求項1記載のエンドテリン変換酵素の製造法。 5.阻害剤としてホスホラミドンを使用する、請求項4記載の方法。 6.請求項1記載のエンドテリン変換酵素を製造方法において、エンドテリン変 換酵素のための1つの遺伝子を遺伝子プールから単離するために、SEQ ID NO:36の部分配列をコード化するかまたは配列相補性にするオリゴヌクレ オチドをハイブリッド化試料として使用し、この遺伝子を常用の遺伝子技術的方 法で宿主有機体中で発現させることを特徴とする、請求項1記載のエンドテリン 変換酵素の製造法。 7.エンドテリン変換酵素の阻害剤の同定のための請求項1記載のエンドテリン 変換酵素の使用。 8.抗体の製造のための請求項1記載のエンドテリン変換酵素の使用。 9.請求項2記載のDNA配列の1つまたはそれ以上のエクストラコピーを含有 するかまたは標準のEXE遺伝子が遮断されているような形質転換された動物を 得るための請求項2記載のDNA配列の使用。 10.医薬を製造するための請求項1記載のエンドテリン変換酵素の使用。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19934339100 DE4339100A1 (de) | 1993-11-16 | 1993-11-16 | Endothelinkonversionsenzym-1 (ECE-1) |
DE19944403665 DE4403665A1 (de) | 1994-02-07 | 1994-02-07 | Endothelinkonversionsenzym (ECE) |
DE19944412372 DE4412372A1 (de) | 1994-04-12 | 1994-04-12 | Endothelinkonversionsenzym (ECE) |
DE4412372.8 | 1994-04-12 | ||
DE4403665.5 | 1994-04-12 | ||
DE4339100.1 | 1994-04-12 | ||
PCT/EP1994/003706 WO1995014095A1 (de) | 1993-11-16 | 1994-11-10 | Endothelinkonversionsenzym (ece) |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09505733A true JPH09505733A (ja) | 1997-06-10 |
Family
ID=27205762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7514199A Ceased JPH09505733A (ja) | 1993-11-16 | 1994-11-10 | エンドテリン変換酵素 |
Country Status (18)
Country | Link |
---|---|
US (1) | US6066502A (ja) |
EP (1) | EP0728209B1 (ja) |
JP (1) | JPH09505733A (ja) |
KR (1) | KR960705934A (ja) |
CN (1) | CN1141651A (ja) |
AT (1) | ATE315656T1 (ja) |
AU (1) | AU8107094A (ja) |
BR (1) | BR9408077A (ja) |
CA (1) | CA2176507A1 (ja) |
CZ (1) | CZ139496A3 (ja) |
DE (1) | DE59410427D1 (ja) |
FI (1) | FI962047A (ja) |
HU (1) | HUT75554A (ja) |
NO (1) | NO962023L (ja) |
NZ (1) | NZ275817A (ja) |
PL (1) | PL314480A1 (ja) |
SK (1) | SK59896A3 (ja) |
WO (1) | WO1995014095A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6255468B1 (en) * | 1998-05-07 | 2001-07-03 | Smithkline Beecham Plc | MPROT12 polynucleotides and methods thereof |
US6524840B1 (en) | 1999-09-24 | 2003-02-25 | Lexicon Genetics Incorporated | Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
ATE312351T1 (de) * | 2004-02-13 | 2005-12-15 | Brahms Ag | Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens |
WO2009018209A1 (en) | 2007-07-27 | 2009-02-05 | The Regents Of The University Of Colorado, A Body Corporate | ENDOTHELIN SINGLE NUCLEOTIDE POLYMORPHISMS AND METHODS OF PREDICTING β-ADRENERGIC RECEPTOR TARGETING AGENT EFFICACY |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2966939B2 (ja) * | 1990-12-07 | 1999-10-25 | 日清製粉株式会社 | ヒト細胞由来のエンドセリン変換酵素 |
EP0575405A1 (en) * | 1991-02-04 | 1993-12-29 | Berlex Laboratories, Inc. | Endothelin converting enzyme |
-
1994
- 1994-11-10 AT AT95900130T patent/ATE315656T1/de not_active IP Right Cessation
- 1994-11-10 WO PCT/EP1994/003706 patent/WO1995014095A1/de active IP Right Grant
- 1994-11-10 KR KR1019960702556A patent/KR960705934A/ko not_active Application Discontinuation
- 1994-11-10 US US08/646,273 patent/US6066502A/en not_active Expired - Lifetime
- 1994-11-10 EP EP95900130A patent/EP0728209B1/de not_active Expired - Lifetime
- 1994-11-10 BR BR9408077A patent/BR9408077A/pt not_active Application Discontinuation
- 1994-11-10 JP JP7514199A patent/JPH09505733A/ja not_active Ceased
- 1994-11-10 CN CN94194828A patent/CN1141651A/zh active Pending
- 1994-11-10 NZ NZ275817A patent/NZ275817A/en not_active IP Right Cessation
- 1994-11-10 PL PL94314480A patent/PL314480A1/xx unknown
- 1994-11-10 CA CA002176507A patent/CA2176507A1/en not_active Abandoned
- 1994-11-10 AU AU81070/94A patent/AU8107094A/en not_active Abandoned
- 1994-11-10 DE DE59410427T patent/DE59410427D1/de not_active Expired - Fee Related
- 1994-11-10 HU HU9601298A patent/HUT75554A/hu unknown
- 1994-11-10 SK SK598-96A patent/SK59896A3/sk unknown
- 1994-11-10 CZ CZ961394A patent/CZ139496A3/cs unknown
-
1996
- 1996-05-14 FI FI962047A patent/FI962047A/fi unknown
- 1996-05-15 NO NO962023A patent/NO962023L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9408077A (pt) | 1997-08-12 |
CN1141651A (zh) | 1997-01-29 |
NO962023L (no) | 1996-07-16 |
EP0728209B1 (de) | 2006-01-11 |
SK59896A3 (en) | 1997-07-09 |
NO962023D0 (no) | 1996-05-15 |
DE59410427D1 (en) | 2006-04-06 |
HU9601298D0 (en) | 1996-07-29 |
CZ139496A3 (en) | 1997-10-15 |
AU8107094A (en) | 1995-06-06 |
FI962047A (fi) | 1996-07-12 |
CA2176507A1 (en) | 1995-05-26 |
KR960705934A (ko) | 1996-11-08 |
HUT75554A (en) | 1997-05-28 |
NZ275817A (en) | 1997-02-24 |
ATE315656T1 (de) | 2006-02-15 |
FI962047A0 (fi) | 1996-05-14 |
WO1995014095A1 (de) | 1995-05-26 |
EP0728209A1 (de) | 1996-08-28 |
US6066502A (en) | 2000-05-23 |
PL314480A1 (en) | 1996-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Faucheu et al. | A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells. | |
KR101126423B1 (ko) | 보체 활성화를 억제하는 변형된 프로테아제 | |
FI100403B (fi) | Menetelmä glykosyloitujen tai glykosyloimattomien vampyyrilepakon sylj en plasminogeeniaktivaattoreiden valmistamiseksi | |
EP0383417B1 (en) | Vampire bat salivary Plasminogen activator vPA-alpha 1 | |
JPH0673456B2 (ja) | ヒト・膵臓エラスタ−ゼ▲i▼ | |
RU2018535C1 (ru) | Способ получения зимогенной формы человеческого белка с | |
JPH07506959A (ja) | コラーゲン誘発血小板凝集抑制剤 | |
JPH09149790A (ja) | 新規セリンプロテアーゼ | |
JPH09505733A (ja) | エンドテリン変換酵素 | |
US6664383B1 (en) | Polypeptides, cDNA encoding the same and utilization thereof | |
JP2002034566A (ja) | ミミズ由来セリンプロテアーゼの遺伝子、当該遺伝子を含むプラスミドベクター及び形質転換体 | |
US5661000A (en) | Serine protease and serine protease gene | |
EP0927764B1 (de) | Chimäre Serinproteasen | |
JPH03505276A (ja) | 再配列された組織プラスミノーゲン活性化因子及びその産生方法 | |
JPH11514228A (ja) | リポ蛋白結合ホスホリパーゼA2(Lp−PLA2)PAFアセチルヒドロラーゼに対して配列相同性を有する化合物 | |
EP0307478A1 (en) | Serine protease and serine protease gene | |
JP2774156B2 (ja) | ヒトプロテインcおよび/または活性化ヒトプロテインc様活性を有する蛋白 | |
AU619803B2 (en) | Rearranged tissue plasminogen activators and method for producing same | |
JPH06500070A (ja) | 新規タンパク質及びその製造 | |
JPH0453489A (ja) | プロウロキナーゼの遺伝子工学的製造法 | |
JPH07316199A (ja) | ラットプロテア−ゼインヒビタ− | |
DE4403665A1 (de) | Endothelinkonversionsenzym (ECE) | |
JPH0559099A (ja) | ラツトプロテア−ゼインヒビタ− | |
JPH09157300A (ja) | プロテアーゼインヒビター | |
JPH07163367A (ja) | ヒトt細胞由来プロリルエンドペプチダーゼ産生遺伝子断片および該エンドペプチダーゼの製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040302 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040528 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050125 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050422 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050613 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20050905 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051025 |